[ET Net News Agency, 14 November 2019] Daiwa Research raised its target price for Ping
An Healthcare and Technology (Good Doctor)(01833) to HK$62 from HK$60 and maintained its
"buy" rating.
The research house said PA Good Doctor launched "Private Doctor" product in June, which
offers proactive online medical consultation and comprehensive offline services (such as
fast-track appointments and outpatient escort). This product has a higher ASP (CNY500,
versus "Health 360": CNY199) and decent margin (40-50%), and targets out-of-pocket
medical payments. The current backlog for "Private Doctor" reached CNY300m and revenue
will be gradually recognised over 1-year horizon.
Daiwa cut its 2021 EPS estimates by 8%, mainly due to slower-than-expected growth
momentum in the health mall segment. (KL)